Trial Site Detail

 

Drug:
BGT226
Trial:
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
Conditions: Solid Tumors
Trial Status:
Completed

 

Princess Margaret Hospital

610 University Ave     
Toronto , ON M5G 2M9
Canada

 

Principal Investigator:
Lillian Siu, M.D.
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Princess Margaret Hospital Website:
http://www.uhn.ca/index.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.